SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cytori Therapeutics, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: SnowShredder7/17/2009 12:11:25 PM
  Read Replies (2) of 251
 
Cytori's Celution® 700 System to be Regulated as a Medical Device by U.S. FDA

finance.yahoo.com

Best of Luck,

SS

>>>>>>>>>
Cytori's Celution® 700 System to be Regulated as a Medical Device by U.S. FDA

Press Release
Source: Cytori Therapeutics
On Friday July 17, 2009, 7:00 am EDT
Buzz up! 0
Print
Companies: Cytori therapeutics, inc.
SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ:CYTX - News) was informed by the U.S. Food and Drug Administration (FDA) that the Celution® 700 System will be regulated as a medical device under the Federal Food, Drug, and Cosmetic Act. This determination, in response to Cytori’s Request for Designation, clears the way for Cytori to compile and submit a marketing application to the FDA for the Celution® 700 System for use as a medical device in aesthetic body contouring and/or filling of soft tissue voids.

Related Quotes
Symbol Price Change
CYTX 3.52 +0.24

“This important decision provides greater clarity of our regulatory path in the U.S. and is consistent with our interpretation of current device regulations,” said Christopher J. Calhoun, chief executive officer for Cytori. “We are preparing for the next steps in the process of working with the FDA to determine the specific device marketing application to submit, including whether clinical evaluations will be necessary.”

Based on the jurisdictional determination from the FDA, marketing applications for the Celution® 700 device will be reviewed by the FDA’s Center for Biologics Evaluation and Research under the law applicable to medical devices. Clinical investigations, if required, would be conducted in accordance with the Investigational Device Exemption (IDE) regulations, not the Investigational New Drug regulations applicable to drugs and biologics.

...(snip)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext